Kbc Group Nv Editas Medicine, Inc. Transaction History

Kbc Group Nv

$31.5 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$26.55 - $40.57 $59,737 - $91,282	-2,250 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$39.27 - $72.94 $58,905 - $109,410	-1,500 Reduced 40.0%	2,250 $92,000
Q1 2021 Apr 26, 2021	BUY	$39.71 - $90.58 $39,710 - $90,580	1,000 Added 36.36%	3,750 $158,000
Q4 2020 Feb 10, 2021	SELL	$27.07 - $84.35 $39,251 - $122,307	-1,450 Reduced 34.52%	2,750 $193,000
Q2 2020 Aug 10, 2020	SELL	$18.5 - $34.34 $46,250 - $85,850	-2,500 Reduced 37.31%	4,200 $124,000

Q4 2019 Feb 11, 2020	BUY	$19.49 - $32.63 $110,703 - $185,338	5,680 Added 556.86%	6,700 $198,000
Q3 2019 Nov 07, 2019	SELL	$22.49 - $26.81 $67,020 - $79,893	-2,980 Reduced 74.5%	1,020 $23,000
Q2 2019 Dec 03, 2019	BUY	$20.48 - $27.76 $81,920 - $111,040	4,000 New	4,000 $99,000
Q2 2019 Jul 30, 2019	SELL	$20.48 - $27.76 $81,920 - $111,040	-4,000 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$19.43 - $26.41 $77,720 - $105,640	4,000 New	4,000 $98,000
Q1 2019 May 10, 2019	SELL	$19.43 - $26.41 $31,088 - $42,256	-1,600 Closed	0 $0
Q4 2018 Dec 03, 2019	BUY	$18.19 - $31.79 $29,104 - $50,864	1,600 New	1,600 $36,000
Q4 2018 Jan 31, 2019	SELL	$18.19 - $31.79 $29,104 - $50,864	-1,600 Closed	0 $0
Q3 2018 Dec 03, 2019	BUY	$27.65 - $38.39 $44,240 - $61,424	1,600 New	1,600 $51,000
Q3 2018 Nov 14, 2018	SELL	$27.65 - $38.39 $44,240 - $61,424	-1,600 Closed	0 $0
Q2 2018 Dec 03, 2019	BUY	$31.4 - $41.01 $50,240 - $65,616	1,600 New	1,600 $57,000
Q2 2018 Aug 03, 2018	SELL	$31.4 - $41.01 $50,240 - $65,616	-1,600 Closed	0 $0
Q1 2018 Dec 03, 2019	BUY	$29.84 - $44.08 $47,744 - $70,528	1,600 New	1,600 $53,000
Q1 2018 May 09, 2018	SELL	$29.84 - $44.08 $47,744 - $70,528	-1,600 Closed	0 $0
Q4 2017 Dec 03, 2019	BUY	$21.89 - $31.34 $35,024 - $50,144	1,600	1,600 $49,000

Others Institutions Holding EDIT

# of Institutions

243

Shares Held

69.3M

Call Options Held

564K

Put Options Held

428K

State Street Corp Boston, MA

8.76M
Shares

$40.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.56M
Shares

$40 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.83M
Shares

$36.6 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.53M
Shares

$25.8 Million
1.35% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.61M
Shares

$12.2 Million
0.01% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $321M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account